461 related articles for article (PubMed ID: 17705241)
21. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
22. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.
Yu HN; Yin JJ; Shen SR
J Agric Food Chem; 2004 Feb; 52(3):462-6. PubMed ID: 14759133
[TBL] [Abstract][Full Text] [Related]
24. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A
Cancer Res; 2001 Sep; 61(18):6777-82. PubMed ID: 11559550
[TBL] [Abstract][Full Text] [Related]
25. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
26. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
28. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.
Siddiqui IA; Adhami VM; Afaq F; Ahmad N; Mukhtar H
J Cell Biochem; 2004 Feb; 91(2):232-42. PubMed ID: 14743383
[TBL] [Abstract][Full Text] [Related]
29. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
31. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
[TBL] [Abstract][Full Text] [Related]
32. Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway.
Ku HC; Liu HS; Hung PF; Chen CL; Liu HC; Chang HH; Tsuei YW; Shih LJ; Lin CL; Lin CM; Kao YH
Mol Nutr Food Res; 2012 Apr; 56(4):580-92. PubMed ID: 22495985
[TBL] [Abstract][Full Text] [Related]
33. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
34. Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants.
Tam NN; Nyska A; Maronpot RR; Kissling G; Lomnitski L; Suttie A; Bakshi S; Bergman M; Grossman S; Ho SM
Prostate; 2006 Jan; 66(1):57-69. PubMed ID: 16114064
[TBL] [Abstract][Full Text] [Related]
35. Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells.
Guo S; Lu J; Subramanian A; Sonenshein GE
Cancer Res; 2006 May; 66(10):5322-9. PubMed ID: 16707458
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK.
Kundu JK; Surh YJ
Ann N Y Acad Sci; 2007 Jan; 1095():504-12. PubMed ID: 17404063
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells.
Morrissey C; Brown M; O'Sullivan J; Weathered N; Watson RW; Tenniswood M
Int J Urol; 2007 Jun; 14(6):545-51. PubMed ID: 17593102
[TBL] [Abstract][Full Text] [Related]
39. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
